Cross-source evidence timeline
Enfuvirtide research timeline
Follow 49 selected, directly cited source records from March 13, 2003 through October 11, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Enfuvirtide.↗
PubMed lists PMID 14664654 in Drugs as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2003 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.↗
PubMed lists PMID 19461505 in AIDS (London, England) as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-07-17 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 17, 2009 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00302822↗
PeptideScanner retained ClinicalTrials.gov record NCT00302822 at 2026-11-16T01:41:15.051Z. Its registry update date was 2026-04-07, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00120367↗
PeptideScanner retained ClinicalTrials.gov record NCT00120367 at 2026-11-16T01:41:15.051Z. Its registry update date was 2026-04-02, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Literature metadata
[Spanish recommendations for proper use of enfuvirtide].↗
PubMed lists PMID 17288910 in Enfermedades infecciosas y microbiologia clinica as Consensus Statement, Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2007-02 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 2007 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2025
Literature metadata
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.↗
PubMed lists PMID 20001856 in The Journal of infectious diseases as Clinical Trial, Journal Article, with publication-date metadata of 2010-01-15 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 15, 2010 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2023
Literature metadata
Development of a HPLC fluorometric method for the quantification of enfuvirtide following in vitro releasing studies on thermosensitive in situ forming gel.↗
PubMed lists PMID 37120679 in Drug delivery and translational research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-04-29 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 29, 2023 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2022
Literature metadata
Enfuvirtide biosynthesis in thermostable chaperone-based fusion.↗
PubMed lists PMID 35646620 in Biotechnology reports (Amsterdam, Netherlands) as Journal Article, with publication-date metadata of 2022-05-14 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 14, 2022 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2021
Literature metadata
Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment.↗
PubMed lists PMID 17389560 in Journal of clinical pharmacology as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2007-04 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 2007 · month precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT01836068↗
PeptideScanner retained ClinicalTrials.gov record NCT01836068 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-23, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00537394↗
PeptideScanner retained ClinicalTrials.gov record NCT00537394 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-04, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00001118↗
PeptideScanner retained ClinicalTrials.gov record NCT00001118 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00031044↗
PeptideScanner retained ClinicalTrials.gov record NCT00031044 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00051831↗
PeptideScanner retained ClinicalTrials.gov record NCT00051831 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00344760↗
PeptideScanner retained ClinicalTrials.gov record NCT00344760 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-05-11, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2019
Literature metadata
[Enfuvirtide: first drug of a new family of antiretroviral agents].↗
PubMed lists PMID 16433570 in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria as Journal Article, Review, with publication-date metadata of 2005 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2005 Nov-Dec · source-text precisionAdded to PeptideScanner November 16, 2026Literature metadata
Enfuvirtide.↗
PubMed lists PMID 15148534 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2004-03 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 2004 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Reassessment of enfuvirtide's role in the management of HIV-1 infection.↗
PubMed lists PMID 18710359 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2008-09 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 2008 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Enfuvirtide.↗
PubMed lists PMID 12457443 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2002-12 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2002 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Immunological and virological study of enfuvirtide-treated HIV-positive patients.↗
PubMed lists PMID 15280778 in AIDS (London, England) as Clinical Trial, Clinical Trial, Phase III, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004-08-20 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 20, 2004 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.↗
PubMed lists PMID 15316339 in AIDS (London, England) as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2004-09-03 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 3, 2004 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART.↗
PubMed lists PMID 12562683 in The Journal of antimicrobial chemotherapy as Journal Article, Review, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 2003 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2018
Literature metadata
Enfuvirtide (T-20): potentials and challenges.↗
PubMed lists PMID 15538017 in The Journal of the Association of Nurses in AIDS Care : JANAC as Journal Article, Review, with publication-date metadata of 2004 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2004 Nov-Dec · source-text precisionAdded to PeptideScanner November 16, 2026Literature metadata
Pharmacokinetics of enfuvirtide in pediatric human immunodeficiency virus 1-infected patients receiving combination therapy.↗
PubMed lists PMID 15626952 in The Pediatric infectious disease journal as Clinical Trial, Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Multicenter Study, and 1 more PubMed publication type, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2004 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
[Therapeutic indications, antiretroviral treatment optimization and quality of life of patients taking enfuvirtide].↗
PubMed lists PMID 15742551 in Medecine et maladies infectieuses as Journal Article, Review, with publication-date metadata of 2004-09 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 2004 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.↗
PubMed lists PMID 16759047 in Antiviral therapy as Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006 (year precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2006 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
Enfuvirtide antiviral activity despite rebound viremia and resistance mutations: fitness tampering or a case of persistent braking on entering?↗
PubMed lists PMID 17205468 in The Journal of infectious diseases as Editorial, Review, Comment, with publication-date metadata of 2006-12-21 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 21, 2006 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Anti-HIV agents. T-20 (enfurvirtide, Fuzeon).↗
PubMed lists PMID 17225316 in TreatmentUpdate as Controlled Clinical Trial, Journal Article, Newspaper Article, with publication-date metadata of 2005 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2005 Jan-Feb · source-text precisionAdded to PeptideScanner November 16, 2026Literature metadata
Enfuvirtide: from basic investigations to current clinical use.↗
PubMed lists PMID 20977403 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2010-11 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 2010 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Enfuvirtide: antiretroviral class 4, drug 1.↗
PubMed lists PMID 15002081 in HIV clinical trials as Journal Article, Review, with publication-date metadata of 2004 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2004 Jan-Feb · source-text precisionAdded to PeptideScanner November 16, 2026Literature metadata
Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.↗
PubMed lists PMID 15199084 in Journal of clinical pharmacology as Clinical Trial, Journal Article, with publication-date metadata of 2004-07 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 2004 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure.↗
PubMed lists PMID 15258964 in Journal of medical virology as Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004-09 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 2004 · month precisionAdded to PeptideScanner November 16, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT02569502↗
PeptideScanner retained ClinicalTrials.gov record NCT02569502 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-11-02, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02582983↗
PeptideScanner retained ClinicalTrials.gov record NCT02582983 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-07-06, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT02733419↗
PeptideScanner retained ClinicalTrials.gov record NCT02733419 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-04-11, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00022763↗
PeptideScanner retained ClinicalTrials.gov record NCT00022763 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-02-15, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2015
Clinical trials
ClinicalTrials.gov record NCT00487188↗
PeptideScanner retained ClinicalTrials.gov record NCT00487188 at 2026-11-16T01:41:15.051Z. Its registry update date was 2015-08-13, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2014
Clinical trials
ClinicalTrials.gov record NCT00624195↗
PeptideScanner retained ClinicalTrials.gov record NCT00624195 at 2026-11-16T01:41:15.051Z. Its registry update date was 2014-04-23, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2012
Clinical trials
ClinicalTrials.gov record NCT00334022↗
PeptideScanner retained ClinicalTrials.gov record NCT00334022 at 2026-11-16T01:41:15.051Z. Its registry update date was 2012-06-05, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2010
Clinical trials
ClinicalTrials.gov record NCT00460382↗
PeptideScanner retained ClinicalTrials.gov record NCT00460382 at 2026-11-16T01:41:15.051Z. Its registry update date was 2010-09-17, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2008
Clinical trials
ClinicalTrials.gov record NCT00657761↗
PeptideScanner retained ClinicalTrials.gov record NCT00657761 at 2026-11-16T01:41:15.051Z. Its registry update date was 2008-04-14, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2006
Literature metadata
Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2.↗
PubMed lists PMID 16706613 in AIDS research and human retroviruses as Clinical Trial, Phase III, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2006-05 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 2006 · month precisionAdded to PeptideScanner November 16, 2026Regulatory
Federal Register notice E6-15554↗
The Federal Register published notice E6-15554, attributed to FDA and its parent HHS department, on 2006-09-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FUZEON,” and PeptideScanner's exact reviewed identity mapping connects the document to Enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2005
Clinical trials
ClinicalTrials.gov record NCT00002239↗
PeptideScanner retained ClinicalTrials.gov record NCT00002239 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-11-15, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00002228↗
PeptideScanner retained ClinicalTrials.gov record NCT00002228 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00008528↗
PeptideScanner retained ClinicalTrials.gov record NCT00008528 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00021554↗
PeptideScanner retained ClinicalTrials.gov record NCT00021554 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00086710↗
PeptideScanner retained ClinicalTrials.gov record NCT00086710 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.↗
Added to PeptideScanner November 16, 2026
Source year
2003
Regulatory
Drugs@FDA application NDA021481↗
The official Drugs@FDA dataset lists original submission 1 for NDA 021481 with status AP dated 2003-03-13, and names enfuvirtide among the application record's active ingredients.↗
Added to PeptideScanner November 16, 2026